Print

New ANDA Cases

Case NameDate FiledJudgeDrugPatent No(s).

Eisai Inc. v. Banner Pharmacaps Inc. , 11-901 (D. Del.)

Oct. 4, 2011

Hon. Gregory M. Sleet

Targretin® (bexarotine capsules)

5,780,676

5,962,731

Pfizer Inc. v. Watson Pharma., Inc. , 11-914 (D. Del.)

Oct. 6, 2011

Hon. Berle M. Schiller

Embeda® (morphine sulfate/naltrexone hydrochloride extended-release capsules)

7,682,633

7,682,634

7,815,934

Pfizer Inc. v. Watson Pharma., Inc. , 11-5860 (D.N.J.)

Oct. 7, 2011

Hon. Claire C. Cecchi

Embeda® (morphine sulfate/naltrexone hydrochloride extended-release capsules)

7,682,633

7,682,634

7,815,934

Novartis Pharma. Corp. v. Alembic Pharma. Ltd. , 11-7092 (S.D.N.Y.)

Oct. 7, 2011

Hon. Harold Baer

Exelon® (rivastigmine tartrate capsules)

5,602,176

Purdue Pharma L.P. v. Ranbaxy, Inc. , 11-7104 (S.D.N.Y.)

Oct. 7, 2011

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride extended release tablet)

7,674,799

7,674,800

7,683,072

Senju Pharma. Co., Ltd. v. Hi-Tech Pharmacal Co., Inc. , 11-1059 (D. Del.)

Oct. 11, 2011

Hon. Sue L. Robinson

Zymaxid® (gatifloxacin ophthalmic solution, 0.5%)

6,333,045

5,880,283

Warner Chilcott Co., LLC v. Watson Pharma., Inc. , 11-5989 (D.N.J.)

Oct. 12, 2011

Hon. Faith S. Hochberg

Atelvia® (risedronate sodium delayed release tablets)

7,645,459

7,645,460

Noven Pharma., Inc. v. Watson Labs., Inc. , 11-5997 (D.N.J.)

Oct. 13, 2011

Hon. Dennis M. Cavanaugh

Daytrana® (methylphenidate transdermal patch)

6,210,705

6,348,211

Schering Corp. v. Actavis Inc. , 11-6067 (D.N.J.)

Oct. 13, 2011

Hon. Jose L. Linares

Vytorin® (ezetimibe/simvastatin tablets)

RE42,461

5,846,966

Alcon Pharma., Ltd. v. Perrigo Co. , 11-0732 (N.D. Tex. )

Oct. 14, 2011

Hon. Terry R. Means

Patanase® (olopatadine  hydrochloride nasal spray, 0.665%)

7,977,376

Novo Nordisk Inc. v. Sandoz Inc. , 11-6106 (D.N.J.)

Oct. 14, 2011

Hon. Freda L. Wolfson

Prandin® (repaglinide tablets)

6,677,358

Janssen Pharma., Inc. v. Sun Pharma Global FZE , 11-6089 (D.N.J.)

Oct. 17, 2011

Hon. Stanley R. Chesler

Ortho Tri-cyclen® LO (norgestimate/ethinyl estradiol tablets)

6,214,815

Alkermes Pharma Ireland Ltd. v. Torrent Pharma. Ltd. , 11-1009 (D. Del.)

Oct. 21, 2011

Hon. Gregory M. Sleet

Luvox CR® (fluvoxamine maleate extended-release capsules)

7,465,462

AstraZeneca AB v. Anchen Pharma., Inc. , 11-6348 (D.N.J.)

Oct. 28, 2011

Hon. Joel A. Pisano

Vimovo® (naproxen and esomeprazole magnesium delayed release tablets)

6,926,907

6,369,085

7,411,070

7,745,466

Abbott Products, Inc. v. Perrigo Co. , 11-6357 (D.N.J.)

Oct. 31, 2011

Hon. Freda L. Wolfson

AndroGel® (testosterone gel)

6,503,894

Senju Pharma. Co., Ltd. v. Hi-Tech Pharmacal Co., Inc. , 11-1059 (D. Del.)

Oct. 31, 2011

Hon. Sue L. Robinson

Zymar® (gatifloxacin ophthalmic solution, 0.3%))

6,333,045

5,880,283

Cephalon, Inc. v. Breckenridge Pharma., Inc. , 11-1070 (D. Del.)

Nov. 2, 2011

Hon. Gregory M. Sleet

Nuvigil® (armodifinil tablets)

7,132,570

Cephalon, Inc. v. Breckenridge Pharma., Inc. , 11-6455 (D.N.J.)

Nov. 3, 2011

Hon. Jose L. Linares

Nuvigil® (armodifinil tablets)

7,132,570

Novartis Pharma. Corp. v. Actavis South Atlantic LLC , 11-1077 (D. Del.)

Nov. 3, 2011

Hon. Sue L. Robinson

Exelon® Patch (rivastigmine transdermal system or extended release film)

5,602,176

6,316,023

6,335,031

Novartis Pharma. Corp. v. Actavis South Atlantic LLC , 11-62371 (S.D. Fla. )

Nov. 4, 2011

Hon. William P. Dimitrouleas

Exelon® Patch (rivastigmine transdermal system or extended release film)

5,602,176

6,316,023

6,335,031

Celgene Corp. v. Actavis South Atlantic LLC , 11-6519 (D.N.J.)

Nov. 4, 2011

Hon. Susan D. Wigenton

Focalin® XR (dexmethylphenidate hydrochloride capsules)

5,908,850

6,355,656

6,528,530

5,837,284

6,635,284

7,431,944

Alkermes Pharma Ireland Ltd. v. Actavis, Inc. , 11-1098 (D. Del.)

Nov. 4, 2011

Hon. Sue L. Robinson

Focalin® XR (dexmethylphenidate hydrochloride capsules)

6,228,398

6,730,325

Warner Chilcott Co., LLC v. Zydus Pharma. (USA) Inc., 11-1105 (D. Del.)

Nov. 8, 2011

Hon. Richard G. Andrews

Asacol® HD (mesalamine delayed-release oral tablet)

6,893,662

Galderma Labs. Inc. v. Amneal Pharma., LLC , 11-1106 (D. Del.)

Nov. 8, 2011

Hon. Leonard P. Stark

Oracea® (doxycycline delayed-release capsules)

7,749,532

7,232,572

7,211,267

Cephalon, Inc. v. Mylan Pharma. Inc. , 11-1111 (D. Del.)

Nov. 9, 2011

Hon. Sue L. Robinson

Fentora® (fentanyl buccal tablets)

6,200,604

6,974,590

7,862,832

7,862,833

Novartis Pharma. Corp. v. Watson Labs. Inc. , 11-1112 (D. Del.)

Nov. 9, 2011

Hon. Sue L. Robinson

Exelon® Patch (rivastigmine transdermal system or extended release film)

5,602,176

6,316,023

6,335,031

Abbott Labs. v. Sandoz Inc. , 11-1113 (D. Del.)

Nov. 9, 2011

Hon. Sue L. Robinson

Simcor® (niacin extended release/simvastatin tablets)

6,080,428

6,469,035

Reckitt Benckiser LLC v. Amneal Pharma. LLC , 11-6609 (D.N.J.)

Nov. 9, 2011

Hon. Joel A. Pisano

Delsym® (dextromethorphan polistirex extended release liquid suspension)

5,980,882

Novartis Pharma. Corp. v. Watson Labs. Inc. , 11-8130 (S.D.N.Y.)

Nov. 10, 2011

Hon. Harold Baer

Exelon® Patch (rivastigmine transdermal system or extended release film)

5,602,176

6,316,023

6,335,031

Purdue Pharma L.P. v. Amneal Pharma., L.L.C. , 11-8153 (S.D.N.Y.)

Nov. 10, 2011

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride extended release tablet)

7,674,799

7,674,800

7,683,072

7,776,314

Celgene Corp. v. Par Pharma., Inc. , 11-6640 (D.N.J.)

Nov. 10, 2011

Hon. Susan D. Wigenton

Focalin® XR (dexmethylphenidate hydrochloride capsules)

5,908,850

6,355,656

6,528,530

5,837,284

6,635,284

7,431,944

Alkermes Pharma Ireland Ltd. v. Par Pharma., Inc. , 11-1119 (D. Del.)

Nov. 11, 2011

Hon. Sue L. Robinson

Focalin® XR (dexmethylphenidate hydrochloride capsules)

6,228,398

6,730,325

Allergan, Inc. v. Lupin Ltd. , 11-611 (E.D. Tex.)

Nov. 11, 2011

Hon. Michael H. Schneider

Lumigan® (bimatoprost ophthalmic solution 0.01%)

7,851,504

Aventis Pharma S.A. v. Strides, Inc. , 11-1121 (D. Del.)

Nov. 14, 2011

Hon. Gregory M. Sleet

Taxotere® (docetaxel injection)

5,714,512

5,750,561

Takeda Pharma. Co. Ltd. v. Hetero Drugs Ltd. , 11-8302 (S.D.N.Y.)

Nov. 16, 2011

Hon. Denise L. Cote

Actos® (pioglitazone

hydrochloride tablets)

5,965,584

6,329,404

6,166,043

Cephalon, Inc. v. Impax Labs., Inc. , 11-1152 (D. Del.)

Nov. 18, 2011

Hon. Sue L. Robinson

Fentora® (fentanyl buccal tablets)

6,200,604

6,974,590

7,862,832

7,862,833

The Medicines Co. v. Sun Pharma Global FZE , 11-6819 (D.N.J.)

Nov. 21, 2011

Hon. Peter G. Sheridan

Angiomax® (bivalirudin intravenous injection)

7,582,727

7,598,343

Warner Chilcott Co., LLC v. Mylan Inc. , 11-6844 (D.N.J.)

Nov. 22, 2011

Hon. Joel A. Pisano

Generess™ Fe (norethindrone and ethinyl estradiol chewable tablet)

6,667,050

Warner Chilcott Co., LLC v. Teva Pharma. USA Inc. , 11-6936 (D.N.J.)

Nov. 22, 2011

Hon. Faith S. Hochberg

Atelvia® (risedronate sodium delayed release tablets)

7,645,459

7,645,460

Bristol-Myers Squibb Co. v. Apotex Inc. , 11-6918 (D.N.J.)

Nov. 23, 2011

Hon. Mary L. Cooper

Sprycel® (dasatinib tablet)

6,596,746

7,125,875

7,153,856

7,491,725

The Medicines Co. v. Sun Pharma Global FZE , 11-15175 (E.D. Mich.)

Nov. 23, 2011

Hon. Bernard A. Friedman

Angiomax® (bivalirudin intravenous injection)

7,582,727

7,598,343

Ferring B.V. v. Watson Pharma., Inc. , 11-853 (D. Nev.)

Nov. 25, 2011

Hon. Larry R. Hicks

Lysteda® (tranexamic acid tablets)

8,022,106

Ferring B.V. v. Apotex, Inc. , 11-854 (D. Nev.)

Nov. 25, 2011

Hon. Larry R. Hicks

Lysteda® (tranexamic acid tablets)

8,022,106

Senju Pharma. Co., Ltd. v. Apotex Inc. , 11-1171 (D. Del.)

Nov. 28, 2011

Hon. Sue L. Robinson

Zymaxid® (gatifloxacin ophthalmic solution, 0.5%)

6,333,045

Alkermes Pharma Ireland Ltd. v. Teva Pharma. USA Inc. , 11-1186 (D. Del.)

Dec. 1, 2011

Hon. Sue L. Robinson

Focalin® XR (dexmethylphenidate hydrochloride capsules)

6,228,398

6,730,325

Abbott Labs. v. Sun Pharma. Indus. Ltd. , 11-1190 (D. Del.)

Dec. 2, 2011

Hon. Sue L. Robinson

Niaspan® (niacin extended release tablet)

6,129,930

6,406,715

6,676,967

6,746,691

6,818,229

7,011,848

Abbott Labs. v. Wockhardt, Ltd. , 11-7046 (D.N.J.)

Dec. 2, 2011

Hon. Dennis M. Cavanaugh

Tricor® (fenofibrate tablet)

6,277,405

7,037,529

7,041,319

Alkermes Pharma Ireland Ltd. v. Wockhardt, Ltd. , 11-7047 (D.N.J.)

Dec. 2, 2011

Hon. Jose L. Linares

Tricor® (fenofibrate tablet)

7,276,249

7,320,802

Celgene Corp. v. Teva Pharma. USA, Inc. , 11-7064 (D.N.J.)

Dec. 2, 2011

Hon. Susan D. Wigenton

Focalin® XR (dexmethylphenidate hydrochloride capsules)

5,908,850

6,355,656

6,528,530

5,837,284

6,635,284

7,431,944

Pfizer Inc. v. Alembic Ltd , 11-1213 (D. Del.)

Dec. 7, 2011

Hon. Gregory M. Sleet

Lyrica® (pregabalin capsules)

6,197,819

Alza Corp. v. Mylan Pharma Inc. , 11-7158 (D.N.J.)

Dec. 8, 2011

Hon. Esther Salas

Glucotrol® XL (glipizide extended release tablets)

5,591,454

Warner Chilcott Co. LLC v. Lupin Ltd. , 11-7228 (D.N.J.)

Dec. 12, 2011

Hon. Joel A. Pisano

Generess™ Fe (norethindrone and ethinyl estradiol chewable tablet)

6,667,050

Janssen Pharma. Inc. v. Sandoz, Inc. , 11-7247 (D.N.J.)

Dec. 13, 2011

Hon. Freda L. Wolfson

Doribax® (doripenem injection)

5,317,016

Cephalon, Inc. v. Celgene Corp. , 11-12226 (D. Mass.)

Dec. 14, 2011

Hon. George A. O’Toole, Jr.

Abraxane® (paclitaxel injection)

RE40,493

Pfizer Inc. v. Sandoz Inc. , 11-1252 (D. Del.)

Dec. 15, 2011

Hon. Gregory M. Sleet

Torisel® (temsirolimus injection)

5,362,718

Pfizer Inc. v. Intas Pharma. Ltd. , 11-1253 (D. Del.)

Dec. 15, 2011

Hon. Leonard P. Stark

Torisel® (temsirolimus injection)

5,362,718

Shire LLC v. Mylan Pharma. Inc. , 11-0201 (N.D. W. Va. )

Dec. 15, 2011

Hon. Irene M. Keeley

Intuniv® (guanfacine hydrochloride extended-release tablets)

6,287,599

6,811,794

5,854,290

Roche Palo Alto LLC v. Dr. Reddy’s Labs., Ltd. , 11-1264 (D. Del.)

Dec. 20, 2011

Hon. Gregory M. Sleet

Valcyte® (valganciclovir hydrochloride)

6,083,953

Allergan, Inc. v. Akorn, Inc. , 11-1270 (D. Del.)

Dec. 21, 2011

Hon. Christopher J. Burke

Acuvail® (ketorolac tromethamine ophthalmic solution, 0.45%)

7,842,714

MSD Consumer Products, Inc. v. Zydus Pharma. (USA) Inc., 11-7437 (D.N.J.)

Dec. 21, 2011

Hon. Peter G. Sheridan

Zegerid OTC™ (omeprazole/sodium bicarbonate capsules)

6,699,885

6,489,346

6,645,988

7,399,772

Santarus, Inc. v. Zydus Pharma. (USA) Inc., 11-7441 (D.N.J.)

Dec. 21, 2011

Hon. Peter G. Sheridan

Zegerid Rx™ (omeprazole/sodium bicarbonate capsules)

6,699,885

6,489,346

6,645,988

7,399,772

GlaxoSmithKline Intellectual Property Management Ltd. v. Sandoz, Inc. , 11-1284 (D. Del.)

Dec. 23, 2011

Hon. Richard G. Andrews

Veramyst® (fluticasone fuorate metered nasal spray)

6,858,596

7,101,866

7,541,350

Merck Frosst Canada & Co. v. Mylan Pharma. Inc. , 11-7569 (D.N.J.)

Dec. 29, 2011

Hon. Freda L. Wolfson

Singulair® (montelukast sodium oral granules eq. to 4 ml base/packet)

8,007,830

Allergan, Inc. v. Lupin Ltd. , 11-0530 (E.D. Tex.)

Dec. 30, 2011

Hon. David Folsom

Acular LS® (ketorolac tromethamine ophthalmic solution, 0.4%)

8,008,338

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.